Drugs / phylloquinone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00062595 | Sep 2000 → Oct 2004 | osteoporosis | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00336232 | May 2006 → Jul 2009 | osteoporosis | Tufts University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01232647 Comparator | Apr 2015 → Mar 2020 | postmenopausal osteoporosis | Guy's and St Thomas' NHS Foundation Trust | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phylloquinone | “phylloquinone (vitamin K1) 500 mcg daily in third month” NCT00336232 ↗ |
| Known as | vitamin K1 | “phylloquinone (vitamin K1) 500 mcg daily in third month” NCT00336232 ↗ |